
James M. Hewitt
Examiner (ID: 13022, Phone: (571)272-7084 , Office: P/3679 )
| Most Active Art Unit | 3679 |
| Art Unit(s) | 3679, 3628 |
| Total Applications | 1889 |
| Issued Applications | 1303 |
| Pending Applications | 154 |
| Abandoned Applications | 447 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5662237
[patent_doc_number] => 20060252833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders'
[patent_app_type] => utility
[patent_app_number] => 11/361069
[patent_app_country] => US
[patent_app_date] => 2006-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10311
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252833.pdf
[firstpage_image] =>[orig_patent_app_number] => 11361069
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/361069 | Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders | Feb 23, 2006 | Abandoned |
Array
(
[id] => 5656616
[patent_doc_number] => 20060142352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Compounds useful for the treatment of cancer, compositions thereof and methods therewith'
[patent_app_type] => utility
[patent_app_number] => 11/357774
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17476
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11357774
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/357774 | Compounds useful for the treatment of cancer, compositions thereof and methods therewith | Feb 16, 2006 | Abandoned |
Array
(
[id] => 5205682
[patent_doc_number] => 20070027164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Agents for treating neurodegenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 11/349653
[patent_app_country] => US
[patent_app_date] => 2006-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 24929
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20070027164.pdf
[firstpage_image] =>[orig_patent_app_number] => 11349653
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/349653 | Agents for treating neurodegenerative diseases | Feb 6, 2006 | Abandoned |
Array
(
[id] => 5912361
[patent_doc_number] => 20060127423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Organic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/343827
[patent_app_country] => US
[patent_app_date] => 2006-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6387
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127423.pdf
[firstpage_image] =>[orig_patent_app_number] => 11343827
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/343827 | Organic compounds | Jan 30, 2006 | Abandoned |
Array
(
[id] => 5596875
[patent_doc_number] => 20060160793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'USE OF MELOXICAM IN COMBINATION WITH AN ANTIPLATELET AGENT FOR TREATMENT OF ACUTE CORONARY SYNDROME AND RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 11/275829
[patent_app_country] => US
[patent_app_date] => 2006-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7102
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11275829
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/275829 | USE OF MELOXICAM IN COMBINATION WITH AN ANTIPLATELET AGENT FOR TREATMENT OF ACUTE CORONARY SYNDROME AND RELATED CONDITIONS | Jan 30, 2006 | Abandoned |
Array
(
[id] => 5595851
[patent_doc_number] => 20060159768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Quetiapine granules'
[patent_app_type] => utility
[patent_app_number] => 11/329378
[patent_app_country] => US
[patent_app_date] => 2006-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3469
[patent_no_of_claims] => 105
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20060159768.pdf
[firstpage_image] =>[orig_patent_app_number] => 11329378
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/329378 | Quetiapine granules | Jan 9, 2006 | Abandoned |
Array
(
[id] => 5368648
[patent_doc_number] => 20090306207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'Treatment of Drug-Resistant Proliferative Disorders'
[patent_app_type] => utility
[patent_app_number] => 11/794524
[patent_app_country] => US
[patent_app_date] => 2006-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13345
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306207.pdf
[firstpage_image] =>[orig_patent_app_number] => 11794524
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/794524 | Treatment of Drug-Resistant Proliferative Disorders | Jan 3, 2006 | Abandoned |
Array
(
[id] => 5673034
[patent_doc_number] => 20060178389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Use of siramesine in the treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/314796
[patent_app_country] => US
[patent_app_date] => 2005-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4607
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178389.pdf
[firstpage_image] =>[orig_patent_app_number] => 11314796
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/314796 | Use of siramesine in the treatment of cancer | Dec 20, 2005 | Abandoned |
Array
(
[id] => 4949971
[patent_doc_number] => 20080306097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-11
[patent_title] => 'Cancer Treatment Method'
[patent_app_type] => utility
[patent_app_number] => 11/721675
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7101
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20080306097.pdf
[firstpage_image] =>[orig_patent_app_number] => 11721675
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/721675 | Cancer Treatment Method | Dec 15, 2005 | Abandoned |
Array
(
[id] => 5595831
[patent_doc_number] => 20060159747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Telmisartan and hydrochlorothiazide combination therapy'
[patent_app_type] => utility
[patent_app_number] => 11/300947
[patent_app_country] => US
[patent_app_date] => 2005-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5302
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20060159747.pdf
[firstpage_image] =>[orig_patent_app_number] => 11300947
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/300947 | Telmisartan and hydrochlorothiazide combination therapy | Dec 14, 2005 | Abandoned |
Array
(
[id] => 5447120
[patent_doc_number] => 20090048346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'THERAPEUTIC FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 11/721662
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11558
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048346.pdf
[firstpage_image] =>[orig_patent_app_number] => 11721662
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/721662 | THERAPEUTIC FORMULATIONS | Nov 29, 2005 | Abandoned |
Array
(
[id] => 5844554
[patent_doc_number] => 20060122217
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Combination of organic compounds'
[patent_app_type] => utility
[patent_app_number] => 11/291008
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4868
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122217.pdf
[firstpage_image] =>[orig_patent_app_number] => 11291008
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/291008 | Combination of organic compounds | Nov 29, 2005 | Abandoned |
Array
(
[id] => 4786258
[patent_doc_number] => 20080139587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/718927
[patent_app_country] => US
[patent_app_date] => 2005-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5151
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139587.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718927
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718927 | Combinations Comprising Epothilones and Protein Tyrosine Kinase Inhibitors and Pharmaceutical Uses Thereof | Nov 27, 2005 | Abandoned |
Array
(
[id] => 5716100
[patent_doc_number] => 20060079463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Anticancer compositions comprising methenamine'
[patent_app_type] => utility
[patent_app_number] => 11/283468
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6297
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079463.pdf
[firstpage_image] =>[orig_patent_app_number] => 11283468
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283468 | Anticancer compositions comprising methenamine | Nov 17, 2005 | Abandoned |
Array
(
[id] => 5331391
[patent_doc_number] => 20090111868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'Use Of Rottlerin And Its Derivatives As Activators Of BK Channel For Therapy Of Hypertension And Related Disorders'
[patent_app_type] => utility
[patent_app_number] => 11/792202
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10129
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111868.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792202
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792202 | Use Of Rottlerin And Its Derivatives As Activators Of BK Channel For Therapy Of Hypertension And Related Disorders | Nov 17, 2005 | Abandoned |
Array
(
[id] => 5199792
[patent_doc_number] => 20070299110
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-27
[patent_title] => 'Novel Tetrazole Derivatives as Positive Allosteric Modulators of Metabotropic Glutamate'
[patent_app_type] => utility
[patent_app_number] => 11/667096
[patent_app_country] => US
[patent_app_date] => 2005-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13571
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20070299110.pdf
[firstpage_image] =>[orig_patent_app_number] => 11667096
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/667096 | Novel Tetrazole Derivatives as Positive Allosteric Modulators of Metabotropic Glutamate | Nov 1, 2005 | Abandoned |
Array
(
[id] => 5034121
[patent_doc_number] => 20070098660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-03
[patent_title] => 'Methods and compositions for epilation'
[patent_app_type] => utility
[patent_app_number] => 11/260769
[patent_app_country] => US
[patent_app_date] => 2005-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5139
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20070098660.pdf
[firstpage_image] =>[orig_patent_app_number] => 11260769
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/260769 | Methods and compositions for epilation | Oct 26, 2005 | Abandoned |
Array
(
[id] => 5603041
[patent_doc_number] => 20060293386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Method for treating cancer'
[patent_app_type] => utility
[patent_app_number] => 11/256747
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4206
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20060293386.pdf
[firstpage_image] =>[orig_patent_app_number] => 11256747
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/256747 | Method for treating cancer | Oct 23, 2005 | Abandoned |
Array
(
[id] => 5648290
[patent_doc_number] => 20060134022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Salivary stimulatory compositions and method of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/256365
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1505
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134022.pdf
[firstpage_image] =>[orig_patent_app_number] => 11256365
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/256365 | Salivary stimulatory compositions and method of use thereof | Oct 20, 2005 | Abandoned |
Array
(
[id] => 5570374
[patent_doc_number] => 20090253752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'COMBINATION OF DPP-IV INHIBITOR, PPAR ANTIDIABETIC AND METMORFIN'
[patent_app_type] => utility
[patent_app_number] => 11/577941
[patent_app_country] => US
[patent_app_date] => 2005-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15118
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253752.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577941
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577941 | COMBINATION OF DPP-IV INHIBITOR, PPAR ANTIDIABETIC AND METMORFIN | Oct 20, 2005 | Abandoned |